New Application for Enzyme Environmental Solutions Formula in South Korea
CEO Travels to South Korea to Meet With Government and Corporate Entities Regarding Biotech
FORT WAYNE, IN--(MARKET WIRE)--Mar 13, 2009 -- (Other OTC:EESO.PK - News) -- Outstanding test results on formulas have called for a meeting ahead of schedule. Enzyme Environmental Solutions CEO, Jared Hochstedler, is leaving for South Korea this Saturday (March 14th - March 18th, 2009) to visit with decision makers from three large corporations, one of which is a household name, internationally; as well, officials from the Korean government are set to meet with Hochstedler regarding their findings on EESO biotech and its several potential applications which would have a positive long-term effect on their overall economy. Their findings, including the FG-500's effect on food and garbage remediation and the Pit Solutions odor and noxious gas remediator on hog farms, have led to findings that support EESO biotech for immediate application on sewage treatment.
"The several applications that each formula can present are impressive, and I'm really glad to see that they are embracing our technology and going outside the box to support the fact that enzymes can fulfill many roles, and I can only imagine the impact that using our biotech for sewage treatment here would have both for EESO and South Korea," states Hochstedler. "I think a contract with South Korean entities -- both corporate and governmental -- will be a great way for the company to gain some exposure toward servicing other governments, and we're honored to be able to meet in person again with those that have taken steps to be truly progressive in terms of Green systems and solutions. The timing of our negotiations with South Korea in combination with the recent U.S. stimulus announcement for research in domestic odor remediation have already garnered unsolicited interest from industrial entities in Ohio and Iowa regarding our hog odor remediation technology."
Craig Douglass, CEO of Loss Prevention Management & Consulting (LPMC), will be accompanying Hochstedler on the trip as representative of Bo and Su Lee who are controlling parties in both U.S. and South Korean corporations including the progressive Star Towers (www.star-towers.com) project in Atlanta, Georgia which includes high end condo, hotel, retail and office facilities in the heart of one of the most progressive cities in the U.S. In a unique move toward company transparency, EESO has partnered with LPMC to provide flight and accommodations for an EESO shareholder who will attend certain meetings that relate to that which has already been publicly released. "Our overall move toward furthering company transparency for shareholders will include both traditional and original moves and I think this definitely falls under the category of original. It will be important to maintain company integrity by keeping all that has not been released publicly behind closed doors, but I think its equally important to be able to allow for a shareholder in the company to witness, firsthand, the statements and findings that have been reported publicly to date. In addition to this, on the more traditional track, as a response to an overwhelming request, EESO will be releasing its financials in fully audited form by end of Q3 2009. In the meantime, we are in process of having them verified by a qualified legal professional and will be re-posted as such on Pink Sheets OTC when the process is complete," says Hochstedler.
Safe Harbor: This release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approvals for anticipated actions.
Contact: Contact: Newbauer Media Relations Email: mark@enzymeconsultants.com